The effect of methadone maintenance on illicit Opioid use, human immunodeficiency virus and hepatitis C virus infection, health status, employment, and criminal activity among heroin abusers during 6 months of treatment in China

Journal of Addiction Medicine

Volumn 1, Issue 4, 2007, Pages 186-190

  Shi, Jie ^a   Zhao, Li Yan ^a   Epstein, David H ^b   Zhao, Chengzheng ^a   Shuai, Yinliang ^c   Yan, Bin ^c   Jin, Jun ^c   Lu, Lin ^a  

^a PEKING UNIVERSITY   (China)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c Beijing Ankang Hospital   (China)

Author keywords

China; Criminal activity; Depression; Employment activity; HCV infection; Health status; Heroin abuse; HIV infection; Methadone maintenance therapy; Severity of dependence

Indexed keywords

EID: 39749187494     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e318156cc19     Document Type: Article

References (39)

1. Cohen J. HIV/AIDS in China. Poised for takeoff? Science. 2004;304: 1430-1432.
2. Zhao D, Zhao CZ, Liu YH, et al. Drug use and HIV/AIDS in China. Chinese J Drug Depend. 2003;12:246-251.
3. Ma Y, Li ZZ. HIV was first discovered among IDUs in China. Chinese J Epidemiol. 1990;11:184-185.
4. Wang Z. Current epidemics of STDs and HIV/AIDS and control strategies and programs in China. Chinese J Prevent Control of STDs AIDS Suppl. 1998;1-4.
5. HIV/AIDS in China-Update to 2000. China Ministry of Health and National Center for AIDS/STD Control and Prevention: Beijing, China, 2001.
6. HIV/AIDS Surveillance Report in 2003. Edited by Chinese Center for Disease Control and Prevention: Beijing, China, 2004.
7. Joseph H, Appel P. Historical perspectives and public health issues. In: Parrino MW. State Methadone Treatment Guidelines. Treatment Improvement Protocol (TIP) Series 1, Rockville, MD: U.S. Department of Health and Human Services;1993: 11-24 DHHS Pub# (SMA) 93-1991.
8. Kreek MJ, Reisinger M. Substance abuse: a comprehensive textbook. In: Lowinson JH, Ruiz P, Millman RB, et al, eds. The Addict as Patient. Baltimore: Williams & Wilkins; 1997.
9. Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. JAMA. 1998;280:1936-1943.
10. Ball J, Ross A. The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcomes. New York: Springer- Verlag, 1991.
11. Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mount Sinai J Med. 2000;67:347-364.
12. Breslin KT, Malone S. Maintaining the viability and safety of the methadone maintenance treatment program. J Psychoactive Drugs. 2006;38:157-160. (Pubitemid 44141295)
13. Gerra G, Ferri M, Polidori E, et al. Long-term methadone maintenance effectiveness: psychosocial and pharmacological variables. J Subst Abuse Treat. 2003;25:1-8. (Pubitemid 37152490)
14. Sees KL, Delucchi KL, Masson C, et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA. 2000;283:1303-1310. (Pubitemid 30129797)
15. Mattick RP, Breen C, Kimber J, et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews (Online) 2003;CD002209.
16. Anglin MD, Speckart GR, Booth MW, et al. Consequences and costs of shutting off methadone. Addict Behav. 1989;14:307-326. (Pubitemid 19152794)
17. Dole VP, Joseph H. Long-term outcome of patients treated with methadone maintenance. Ann N Y Acad Sci. 1978;311:181-189.
18. Barnett PG, Hui SS. The cost-effectiveness of methadone maintenance. Mount Sinai J Med. 2000;67:365-374.
19. Novick DM, Joseph H, Croxson TS, et al. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. Arch Intern Med. 1990;150:97-99. (Pubitemid 20085208)
20. Simoens S, Matheson C, Bond C, et al. The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence. Br J Gen Pract J Roy Coll Gen Pract. 2005;55:139-146. (Pubitemid 40246929)
21. Tang YL. Heroin addiction and current treatment strategies [in Chinese]. Beijing Med J. 1999;21:45-46.
22. Kerr T, Wodak A, Elliott R, et al. Opioid substitution and HIV/AIDS treatment and prevention. Lancet. 2004;364:1918-1919. (Pubitemid 39574577)
23. Kreek MJ. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann N Y Acad Sci. 2000;909:186-216. (Pubitemid 30462040)
24. Tang YLL. Harm reduction-new strategy in drug abuse prevention and treatment [in Chinese]. Chinese J Drug Abuse Prevent Treat. 1997;4: 12-16.
25. Agency XN. Methadone treatment embodies China's pragmatic efforts in drug/AIDS control. Beijing: Xinhua News Agency, 2004.
26. McLellan AT, Luborsky L, Cacciola J, et al. New data from the Addiction Severity Index. Reliability and validity in three centers. J Nervous Mental Dis. 1985;173:412-423. (Pubitemid 15068966)
27. McLellan AT, Luborsky L, Woody GE, et al. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nervous Mental Dis. 1980;168:26-33. (Pubitemid 10187569)
28. Darke S, Hall W, Wodak A, et al. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict. 1992;87:733-742.
29. Gossop M, Darke S, Griffiths P, et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995;90: 607-614.
30. Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965; 12:63-70.
31. Fry C, Rumbold G, Lintzeris N. The Blood Borne Virus Transmission Risk Assessment Questionnaire (BBVTRAQ): Administration and Procedures Manual. Melbourne: Turning Point Alcohol and Drug Centre. Turning Point Alcohol and Drug Centre Inc., 1998.
32. Hartel DM, Schoenbaum EE. Methadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City. Public Health Rep.1998;113 (Suppl 1):107-115. (Pubitemid 29330152)
33. Lowinson JH, Payte JT, Joseph H. Methadone Maintenance in Substance Abuse: A Comprehensive Textbook. Baltimore: Williams & Wilkins; 1997.
34. Shaham Y, Shufman Scher, et al. Methadone maintenance and clonidine detoxification in the treatment of opiate addicts in Israel: suggesting evidence for cultural differences in the effectiveness of treatment modalities for opiate addiction. Israel J Psychiatry Rel Sci. 1991;28:45-57.
35. China-CDC: UN Theme Group on HIV/AIDS in China, Beijing. 2003.
36. Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. A clinical trail with methadone hydrochloride. JAMA. 1965;193:646-650.
37. Donny EC, Brasser SM, Bigelow GE, et al. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Addiction. 2005; 100:1496-1509. (Pubitemid 41442319)
38. Faggiano F, Vigna-Taglianti F, Versino E, et al. Methadone maintenance at different dosages for opioid dependence. Cochrane Database of Systematic Reviews (Online) 2003;CD002208.
39. Strain EC, Bigelow GE, Liebson IA, et al. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA. 1999;281:1000-1005. (Pubitemid 29143891)